secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVITA Medical, Inc. (RCEL)
CIK:        0001762303
Form:       8-K
Filed at:   2025-06-05T23:59:59+00:00
Accession:  0000950170-25-081880
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AVITA Medical shareholders approve amended incentive plan, increase share reserve by 2.5M
--------------------------------------------------------------------------------

- Amended 2020 Omnibus Incentive Plan approved, increasing share reserve by 2.5M to 6.75M shares.
- All seven director nominees elected; for-votes ranged from 8.6M to 10.0M across candidates.
- Ratified Grant Thornton as independent auditor for FY2025 with 13.4M votes for.
- Approved grants to each of six non-executive directors: 10,022 RSUs and 4,295 options each.
- Approved grant of options to acquire 520,000 shares to CEO James Corbett.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1762303/000095017025081880/0000950170-25-081880-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1762303/000095017025081880/rcel-20250604.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-081880

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer